Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-12-02 00:00:00 ET · period of report 2021-12-01 · accession 0001883850-21-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-02 | 2021-12-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $637.53 | -100 | 22.6K | -0.4% | -$63.8K |
| 2021-12-02 | 2021-11-16 | REGN | RYAN ARTHUR F | Dir | G - Gift | $0.00 | -500 | 22.6K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-01 | S | D | 1 | $636.50 | 22,560 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-01 | S | D | 22 | $637.75 | 22,538 | D | — | — | (F6) Represents volume-weighted average price of sales of 22 shares of Company stock on December 1, 2021 at prices ranging from $637.17 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-12-01 | S | D | 12 | $638.62 | 22,526 | D | — | — | (F7) Represents volume-weighted average price of sales of 12 shares of Company stock on December 1, 2021 at prices ranging from $638.03 to $638.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-12-01 | S | D | 24 | $639.49 | 22,502 | D | — | — | (F8) Represents volume-weighted average price of sales of 24 shares of Company stock on December 1, 2021 at prices ranging from $639.01 to $639.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-12-01 | S | D | 5 | $640.47 | 22,497 | D | — | — | (F9) Represents volume-weighted average price of sales of 5 shares of Company stock on December 1, 2021 at prices ranging from $640.01 to $640.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-12-01 | S | D | 6 | $641.23 | 22,491 | D | — | — | (F10) Represents volume-weighted average price of sales of 6 shares of Company stock on December 1, 2021 at prices ranging from $641.01 to $641.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-11-16 | G | D | 500 | $0.00 | 22,591 | D | — | — | |
| 8 | Common | Common Stock | 2021-12-01 | S | D | 9 | $635.36 | 22,561 | D | — | — | (F5) Represents volume-weighted average price of sales of 9 shares of Company stock on December 1, 2021 at prices ranging from $635.06 to $635.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-12-01 | S | D | 11 | $634.56 | 22,570 | D | — | — | (F4) Represents volume-weighted average price of sales of 11 shares of Company stock on December 1, 2021 at prices ranging from $634.05 to $634.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-12-01 | S | D | 2 | $633.47 | 22,581 | D | — | — | (F3) Represents volume-weighted average price of sales of 2 shares of Company stock on December 1, 2021 at prices ranging from $633.21 to $633.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-12-01 | S | D | 7 | $632.63 | 22,583 | D | — | — | (F2) Represents volume-weighted average price of sales of 7 shares of Company stock on December 1, 2021 at prices ranging from $632.00 to $632.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-12-01 | S | D | 1 | $631.15 | 22,590 | D | — | — |